EAST HILLS, NY–LAWFUEL – Litigation News –Pall Corporation (NYSE:PLL) filed a patent infringement action in the United States District Court for the Eastern District of Pennsylvania against BioQuate, Inc., based in Clearwater, Florida. The suit alleges that BioQuate is manufacturing and selling disposable aseptic connector devices that infringe on a patent on Pall’s KleenpakTM Aseptic Connector. The suit seeks damages and an injunction precluding BioQuate from selling the infringing product.
Pall is a leading provider of integrated filtration solutions to the biopharmaceutical industry and has spearheaded the development of single-use technologies for biopharmaceutical processing. Pall’s Kleenpak Aseptic Connector has been established as the leading aseptic connection device and is an enabling technology that improves the safety and efficiency of single-use processing.
Pall’s proprietary materials and technologies along with the ability to engineer them into useful forms are the cornerstone of the Company’s technical and marketing leadership. Pall Corporation vigorously protects its intellectual property rights. It respects the intellectual property rights of others and expects the same in return.
About Pall Corporation:
Pall Corporation is the global leader in the rapidly growing field of filtration, separation and purification. Pall is organized into two businesses: Life Sciences and Industrial. These businesses provide leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, municipal and industrial water purification, aerospace, transportation and broad industrial markets. Total revenues for fiscal year 2006 were $2.0 billion. The Company headquarters is in East Hills, New York with extensive operations throughout the world. For more information visit Pall at http://www.pall.com/.
Forward Looking Statements
Forward-looking statements contained in this and other written and oral reports are based on current Company expectations and are subject to risks and uncertainties, which could cause actual results to differ materially. All statements regarding future performance, earnings projections, earnings guidance, events or developments are forward-looking statements. Such risks and uncertainties include, but are not limited to: changes in product mix and product pricing particularly as we expand our systems business in which we experience significantly longer sales cycles and less predictable revenue with no certainty of future revenue streams from related consumable product offerings and services; increases in costs of manufacturing and operating costs including energy and raw materials; the Company’s ability to achieve the savings anticipated from cost reduction and margin improvement initiatives including the timing of completion of the facilities rationalization initiative; fluctuations in foreign currency exchange rates and interest rates; regulatory approval and market acceptance of new technologies; changes in business relationships with key customers and suppliers including delays or cancellations in shipments; success in enforcing patents and protecting proprietary products and manufacturing techniques; successful completion or integration of acquisitions; domestic and international competition in the Company’s global markets; and global and regional economic conditions and legislative, regulatory and political developments. The Company makes these statements as of the date of this disclosure and undertakes no obligation to update them.
